Skip to main content
Log in

DCB meets DES

DCB trifft DES

  • Letter to the Editor
  • Published:
Herz Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Unverdorben M, Vallbracht C, Cremers B et al (2009) Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 119(23):2986–2994

  2. Unverdorben M, Kleber FX, Heuer H et al (2010) Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 99(3):165–174

  3. Worthley S, Hendriks R, Worthley M, Whelan A, Walters DL, Whitbourn R et al (2015) Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study. Cardiovascular revascularization medicine: including molecular interventions. doi:10.1016/j.carrev.2015.07.009

  4. Kleber FX, Mathey DG, Rittger H et al (2011) How to use the drug-eluting balloon: recommendations by the German consensus group. EuroIntervention 7(Suppl K: p):K125–8

  5. Huber MS, Mooney JF, Madison J, Mooney MR (1991) Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol 68(5):467–471

  6. Silber S, Albertsson P, Aviles FF et al (2005) Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26(8):804–847

  7. Ong PJ, Kubo T, Watson TJ et al (2016) Angiographic, optical coherence tomography and histology findings from combination of a drug-coated balloon with an everolimus-eluting stent in a porcine model. Int J Cardiol 223:665-668. doi:10.1016/j.ijcard.2016.08.268

  8. Costopoulos C, Latib A, Naganuma T et al (2013) The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease. JACC Cardiovasc Interv 6(11):1153–1159

  9. Mok KH, Wickramarachchi U, Watson T et al (2016) Safety of bailout stenting after paclitaxel-coated balloon angioplasty. Herz 17. doi:10.1007/s00059-016-4502-9

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Kherad.

Ethics declarations

Conflict of interest

F. Krackhardt, M. Noutsias, C. Tschöpe, and B. Kherad declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krackhardt, F., Noutsias, M., Tschöpe, C. et al. DCB meets DES. Herz 42, 696–697 (2017). https://doi.org/10.1007/s00059-016-4529-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-016-4529-y

Keywords

Navigation